Alfred S. Cheng-Lok Cheng
Sar, 999077, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Towards biomarker-driven cancer immunotherapy: the rising of a protein phosphatase regulator.
Journal: Signal transduction and targeted therapy
Published: July 31, 2025
Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential.
Journal: Communications biology
Published: February 03, 2025
Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8/CXCR2 signaling.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 31, 2024
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver.
Journal: Cellular & molecular immunology
Published: December 28, 2021
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis.
Journal: Cancer letters
Published: July 21, 2021
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis.
Journal: Cellular & molecular immunology
Published: April 24, 2020
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma.
Journal: Science translational medicine
Published: October 04, 2019
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
Journal: Cells
Published: May 23, 2019
Last Updated: 09/26/2026